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Abstract
Background: To compare the six-month outcome on mood, cognition and quality of life (QoL) in patients with
severe carotid atherosclerosis (CA) who underwent carotid endarterectomy (CEA) with subjects who refused
treatment.
Methods: Cohort study on consecutive inpatients with CA (stenosis ≥ 50 %) (N = 46; age 72.56 ± 7.26; male 65.2 %).
Intervention cohort: subjects who decided to undergo CEA (N = 35); Control cohort patients who refused CEA
(N = 11). DSM-IV-Psychiatric diagnosis made by clinicians using interviews, QoL measured by Short Form Health
Survey (SF-12); cognitive performance by WAIS Intelligent Coefficient (IC).
Results: The study showed a better improvement during six months in Overall IC, Performance IC and Verbal IC in
the group that underwent CEA. QoL in the two cohorts did not reach statistical significance. Percentages of
patients who improved in the CEA group were significantly higher with regard to Overall and Verbal IC scores, and
at the limits of statistical significance in Performance IC. The differences of subject with improvement in SF-12 score
in the two groups did not reach statistical significance. Ages below 68 were found to be determinant of a good
outcome in Overall IC score. Limit: study conducted with a small sample size.
Conclusions: Patients with severe carotid atherosclerosis who underwent CEA enhanced their cognitive performance.
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Background
Atherosclerosis is a major global issue. While other
causes of mortality have diminished and life expectancy
has increased worldwide, the same is not true for the
former [1, 2]. In fact, atherosclerotic has been the first
cause of mortality in developed countries over the past
decades, but it is estimated that by 2020 cardiovascular
diseases and atherosclerosis will be the major causes of
death also in most developing countries, including China
and India [1, 2]. In this framework, carotid atheroscler-
osis plays an important role because is a determinant of
acute cerebrovascular events such as stroke, the inci-
dence of which in the United States is about 800,000 per
year [3]. Carotid atherosclerosis is also a well-known de-
terminant of early cognitive impairment, a factor associ-
ated with low quality of life and life expectancy in the
elderly [4].
The prevalence of carotid stenosis is about 10 % in
subjects over 70 years of age in the community. The
majority of them present no symptoms of cardiovas-
cular disease and report no acute vascular events [5].
Carotid stenosis can be appropriately treated and
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cerebral vascular attacks and stroke can be prevented.
Both carotid endarterectomy (CEA), which was the
gold standard treatment for many years in the past,
and stenting of carotid lesions (CAS) [6, 7], a more
recent alternative, are today considered to have simi-
lar efficacy and safety [8]. However, the appropriate
treatments are frequently not well accepted by pa-
tients, probably owing to the fact that the disorder is
asymptomatic and the patient does not always feel
the need for treatment [9].
A relevant factor associated with low compliance may
be comorbid depressive and mood disorders. The role of
these disorders as a determinant of negative outcomes in
treated patients also needs to be clarified. In fact, around
20–35 % of patients with carotid atherosclerosis have
been found comorbid with major depressive or mood
disorders [10–12]. Comorbidity with these disorders has
been shown to be associated with poorer clinical out-
comes, mortality, low functional disabilities and quality
of life [12, 13]. Even though an effective treatment of de-
pression has been found to improve the course of coron-
ary heart disease and decrease acute events [13] with
patients’ adherence to procedures, studies on the role of
mood disorders concerning compliance with treatment
for atherosclerosis and carotid atherosclerosis are
lacking.
The co-occurrence of atherosclerosis (and neuro-
vascular diseases in particular) and mood disorders may
influence the evolutionary paths of both diseases [14].
The current concept of vascular depression underlines
these links. Although up to now there is no agreement
on diagnostic criteria for vascular depression [15, 16],
they should be characterized by: 1) late-life onset of de-
pression; 2) hyperintensities in the brain revealed by
Magnetic Resonance Imaging (MRI); 3) severe cognitive
impairment with deficits in executive functioning; 4)
poor response to antidepressants.
The objective of this work is to perform a study of pa-
tients with severe carotid atherosclerosis (CA) eligible
for carotid endarterectomy (CEA) in the six-month out-
come on mood, cognition and quality of life (QoL), com-






Subjects (Table 1) were 46 consecutive inpatients with
carotid atherosclerosis at the Thoracic and Vascular Sur-
gery Clinic of the University Hospital of Cagliari, Italy,
recruited from July 2013 to May 2014 (refusal rate
22 %). The inclusion criteria were: age ≥50 years; symp-
tomatic carotid stenosis above 50 % and/or carriers of
carotid stenosis > 70 % even asymptomatic. Exclusion
criteria were: contraindications to surgical procedures;
cognitive deficits making the study assessment
impossible.
Two cohorts were formed from the study sample: 1)
subjects who agreed and underwent CEA were the Inter-
vention Cohort; 2) subjects who despite the diagnosis
rejected surgery formed the Control Cohort.
Evaluation
At their entrance to the hospital ward all patients under-
went a standardized diagnosis of atherosclerosis. If eli-
gible for the study (and to undergo CEA), they were
given an explanation of the purpose of the study and
were required to give written consent. Those who agreed
to participate were subjected to a standardized assess-
ment of cognitive performance, quality of life and de-
pressive symptoms at study entry (t0). Based on the fact
of accepting or not accepting to undergo CEA, the sam-
ple was subdivided into the two cohorts. In the week
after, those who had agreed to undergo CEA were oper-
ated on.
The same evaluation of cognitive performance, mood
and quality of life was repeated six months (t1) after the
first evaluation both in patients who underwent CEA
and in those who had refused surgery.
The reassessment was made over two months because
of difficulties in contacting patients for administration of
the retest: the patients enrolled were often lost to
follow-up surgery at 6 months because the University
Hospital is a center of excellence and patients living far
away went to local services for checkups after CEA.
Table 1 Recruited sample and Cohort study sample. Comparison by age and gender
Recruited sample (N = 46) Dropouts at t1 (N = 6) Intervention cohort (N = 30) Control cohort (N = 10)
Agea (years) Mean ± ds 72.56 ± 7.26 70.36 ± 7.9 73.16 ± 7.16 72.10 ± 8.75
Genderb
m 30 (65.2 %) 5 (83.3 %) 17 (56.7 %) 8(80 %)
f 16 (34.8 %) 1 (16.6 %) 13 (43,3 %) 2(20 %)
aDropouts at t1 (6) vs Overall Study Sample (40) F = 0.56, DF = 1,44,45, P = 0.455; Intervention (30) vs Control (10) F = 0.14, P = 0.71,DF = 1,38,39
bDropouts at t1 (6) vs Overall Study Sample (40) χ2 (with Yates corr.) = 0.29, DF = 1, P = 0.59; Intervention (30) vs Control (10); χ2 = 2.22, DF = 1, P = 0.26
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However, the evaluation conducted over a 2-month
follow-up (6–7 months) allows a comparison in which
one cannot assume serious discrepancies due to timing.
Psychiatric assessment
The recruited subjects were interviewed by clinicians
(physicians or psychologists with at least 2 years of ex-
perience in psychiatry) by means of the “Advanced
Neuropsychiatric Tools and Assessment Schedule”
(ANTAS) [17], a semi-structured tool derived in part
from the Structured Clinical Interview (SCID) [18]. It al-
lows the pronouncing of a psychiatric diagnosis accord-
ing to DSM-IV criteria [APA 1994]. The diagnoses
derived from the ANTAS were compared for reliability
against those from the SCID, finding an agreement by
means of Cohen’s K = 0.85 [19]. Bipolar Spectrum Disor-
ders (BDs) were screened by means of the Mood Dis-
order Questionnaire (MDQ), Italian version [20]. The
Hamilton Depression Rating Scale (HAM - D) [21] was
used for the assessment of depressive symptoms.
Diagnosis of carotid atherosclerosis
The diagnosis of carotid stenosis in the recruited sample
was performed through clinical examination and Duplex
ultrasound scanning of the epi-aortic trunks and Con-
trast Enhancement Computed Tomography (CECT) of
the neck [22].
Evaluation of cognitive performance
The WAIS-R (Wechsler Adult Intelligence Scale, Re-
vised 1997) [23] consists of eleven sub-tests; six are used
for the evaluation of the verbal coefficient of intelligence
and form the verbal scale (Verbal IC) and five for the
measurement of practical intelligence and form the per-
formance scale (Performance IC) [23]. The sub-tests of
the verbal scale are: information, memory of numbers,
vocabulary, arithmetic reasoning, understanding and
analogies. Those of the performance scale consist of pic-
ture arrangement, picture completion, block design, ob-
ject assembly and digit symbol. Overall, the test consists
of 166 questions and the overall score is used for a gen-
eral measure of intelligence (Overall IC).
Measure of quality of life
The perception of the quality of life in each subject of
the sample was measured by means of the Short Form
Health Survey (SF-12) [24]. The SF-12 is a widely used
tool that measures the perception of quality of life ac-
cording to physical activity, health problems inducing
limitation of activities and goals, emotional status, pain,
perception of general health, vitality, effectiveness of the
social network and mental health. The score is referred
for a period of one month prior to evaluation. Higher
scores on the SF-12 indicated a higher perception of
quality of life.
Data analysis
Comparison between means and standard deviations of
SF-12 scores and other numerical data between the two
cohorts at the start of the follow-up was carried out by
means of ANOVA one-way statistics and for nonpara-
metric variables by the χ2 test.
In line with the stated goals, the two Main Outcome
Measures of the study were: 1) comparison of the aver-
age mean in the two cohorts of the Hamilton, WAIS
and SF-12 scales at the beginning and end of the trial; 2)
comparison of the proportion of patients achieving a
clinically relevant improvement in both groups (Im-
provement Rate). In keeping with the international
literature, the following were considered significant im-
provements: 30 % decrease in the score of the Hamilton
at least a 5-point increase in the SF-12; at least a 10-
point increase in the total score of WAIS and WAIS
verbal and performance. Regarding depressive symptom-
atology, the proportion of patients with a Hamilton
score above or equal to 14, indicative of depressive
symptoms with clinical relevance, was also compared
over time in the two cohorts. The comparison of the
average scores of Hamilton, WAIS, SF-12 at t0 and at
the end of the trial was conducted with multivariate
analysis of variance for repeated data (MANOVA). The
comparison of the proportion of patients with Hamilton
score ≥ 14 in the two cohorts was carried out by means
of the method of Siegel and Castellan [25].
The correlation between the scores of Overall IC and
SF12 was carried out by means of Pearson’s coefficient.
The Castellan test was conducted using scripts devel-
oped ad hoc with R statistical software (R Development
Core Team, 2010). Other statistical analyses were proc-
essed with SPSS 13.0.1 software.
Ethical aspects
The independent ethical committee of the Azienda
Ospedaliero Universitaria of Cagliari, Italy, approved this
study protocol. Each candidate signed an informed con-
sent. The study, due to its observational design, did not
imply any change in the scheduled and proposed treat-
ment of patients. Treatment was defined according to
the clinical judgment and international guidelines and
by patients’ decision to accept the treatment or not.
Results
The recruited sample (see Table 1) consisted of 46 pa-
tients with carotid stenosis; it was composed of 30 men
(65.2 %) and 16 women (34.8 %).
The sample was subsequently divided into two
cohorts:
Carta et al. BMC Psychiatry  (2015) 15:277 Page 3 of 8
The first cohort consisted of 35 patients undergoing
surgery for carotid endarterectomy. This cohort con-
sisted of symptomatic patients with stenosis above 50 %
(n = 11) and/or asymptomatic patients with carotid sten-
osis > 70 % (n = 24).
The second cohort consisted of 11 subjects, including
symptomatic patients with stenosis above 50 % (n = 4)
and/or asymptomatic patients with carotid stenosis >
70 % (n = 7), who, despite the diagnosis, rejected CEA.
Of the symptomatic cases,9 (25.7 %) in the cohort
undergoing surgery and 2 (18.1 %) in the control cohort
showed Transient Ischemic Attack (TIA) (χ 2 with Yates
correction = 0.011, P = 0.986, 1DF); 2 subjects (5.7 %) in
the cohort undergoing surgery and 2 (18.1 %) in the
control cohort showed Stroke (χ 2 with Yates correction
= 0.444, P = 0.505, Degree of Freedom [DF] = 1).
The two cohorts did not differ in the severity of sten-
osis (50-70 % symptomatic or ≥70 % even asymptom-
atic); the two groups were homogeneous in all outcome
measures found at time 0 (Hamilton, SF-12; Overall IC;
Verbal IC and Performance IC scores) or in distribution
by age (Table 1, age F = 0.14, P = 0.71,DF = 1,38,39) or
gender (Table 1, χ2 = 2.22, DF = 1, P = 0.26).
Patients belonging to the two cohorts were contacted
at a distance of 6–7 months for the evaluation (t1). Only
40 subjects (87 %) arrived for the t1 evaluation owing to
six dropouts, 5 in the intervention group [14.3 % of the
initial group] and 1 in the intervention rejecting group
[9.1 % of this initial group]: two patients were unable to
be evaluated owing to health problems that occurred
after surgery not connected with vascular disease (one
person was diagnosed with cancer of the cardia in Sep-
tember 2014 and it was impossible to fix an appoint-
ment after considering the serious health condition, the
second subject was unavailable as hospitalized for ab-
dominal surgery in the period in which the retest was to
be administered); while the other four subjects refused
to be re-evaluated without giving specific reasons.
The final sample (n = 40) of patients did not differ for
age (Tab. 1, F = 0.14, DF = 1,38,39, P = 0.71) or gender
(Tab.1, χ2 with Yates correction =2.22, DF = 1, P = 0.26)
or for severity of the stenosis (Table 1, χ2 with Yates cor-
rection = 0.01, DF = 1, P = 0.99) from the initial sample.
The group of participants who entered the cohort
study was divided as follows: 30 (75 %) patients who
underwent CEA, 17 men (56.7 %), 13 women (43.3 %),
aged 73.16 ± 7.16 (Intervention Cohort); 10 (25 %) pa-
tients who refused CEA, 8 men (80 %), two women
(20 %), aged 72.10 ± 8.75 (Control Cohort) (Table 1).
Table 2 shows the scores (mean ± sd) achieved by
patients of the two cohorts in the outcome measures at
t0 and t1 (SF12, Hamilton, Overall IC, Verbal IC;
Performance IC). The two groups were homogeneous
in all outcome measures found at t0 (1-way ANOVA,
DF = 1,38,39): SF12 (F = 0.01; P = 0.96); Hamilton (F = 0.04;
P = 0.85); Overall IC (F = 1.02; P = 0.32); Verbal IC
(F = 0.41; P = 0.52); Performance IC (F = 1.20: P = 00.28).
The two groups remained homogeneous in the two
evaluations, showing a homogeneous improvement over
time, relative to the mean scores of SF-12 (comparison
[t0-t1] by MANOVA: Time, F = 0.941, Hyp DF = 1, DF =
38, P = 0.338; Groups, F = 0.487, Hyp DF = 1, DF = 38, P
= 0.490; Time x groups, F = 0.099; Hyp DF = 1, DF = 38,
P = 0.755) and Hamilton (comparison [t0-t1] by MAN-
OVA: Time, F = 0.678, Hyp DF = 1, DF = 38, P = 0.416;
Groups, F = 0.218; Hyp DF = 1, DF = 38, P = 0.664; Time
x groups, F = 0.11, Hyp DF = 1, DF = 38, P = 0.741); the
mean score of the Overall IC showed an improvement
in time with a time-effect group, with a greater increase
in the CEA group compared to the control group (com-
parison res [t0-t1] by MANOVA: Time, F = 8.871, Hyp
DF = 1, DF = 38, P = 0.005; Groups: F = 1.789; Hyp DF =
1, DF = 38, P = 0.198; Time x groups: F = 0.111, Hyp DF
= 1, DF = 38, P = 0.014; final score 105.77 ± 19.91 vs.
93.40 ± 20:47); a similar result was evident in relation to
the Verbal IC score (comparison [t0-t1] by MANOVA:
Time, F = 10.569, Hyp DF = 1, DF = 38, P = 0.002;
Groups, F = 1,206; Hyp DF = 1, DF = 38, P = 0.279; Time
x groups, F = 5.853, Hyp DF = 1, DF = 38, P = 0.020) and
to the Performance IC (comparison [t0-t1] by MAN-
OVA: Time, F = 3.328, Hyp DF = 1, DF = 38, P = 0.076;
Groups, F = 2.291, Hyp DF = 1, DF = 38, P = 0.138; Time
x groups, F = 4.860, Hyp DF = 1, DF = 38, P = 0.034)
(Table 2).
In the sub-cohort of those who underwent surgery, 12
people (40 %) showed an improvement in the SF-12
Table 2 SF12, Hamilton, Overall IC (WAIS), Verbal IC (WAIS); Performance IC (WAIS) scores (mean ± sd ) at t0 and t1 in the two
cohorts
Tool Score t0 Intervention Cohort (CEA) Score t1 Intervention Cohort (CEA) Score t0 Control Cohort Score t1 Control Cohort
SF-12 31.70 ± 7.58 32.57 ± 7.31 29.60 ± 6.93 31.30 ± 8.62
Hamilton 6.83 ± 6.44 6.37 ± 6.59 8.20 ± 8.55 7.10 ± 5.62
Overall IC 98.63 ± 17.61 105.77 ± 19.91 92.90 ± 18.57 93.40 ± 20.47
Verbal IC 100.53 ± 17.57 108.03 ± 20.09 96.40 ± 17.61 97.50 ± 18.14
Performance IC 96.80 ± 16.30 102.10 ± 17.94 90.10 ± 18.18 89.60 ± 20.81
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indicative score against 2 (20 %) in the control group (χ
2 = 1.319; df 1; P = 0.251). Regarding the Hamilton score
in the group receiving CEA, 13 people (44.3 %) resulted
improved, quantified as a decrease of 30 % in the score
against two (20 %) in the control group (χ 2 = 1.742, P =
0.187, DF = 1).
As regards the Overall IC score in the CEA group, 10
patients (33.3 %) showed an increase of at least 10 points
in the score against none in the control group (0 %) (χ 2
= 4.44, DF = 1, P = 0.035). As regards the Verbal IC
score, 9 patients in the CEA group improved at least by
10 points (30 %), vs 0 (0 %) in the control group (χ 2 =
4.44, DF = 1, P = 0.049). In the improvement of Perform-
ance IC the same trend was noted, with 8 patients in
group CEA who improved by at least 10 points
(26.6 %%) against 0 (0 %) in the control group, but, in
this case, the difference did not reach statistical signifi-
cance (χ 2 = 4.44, DF = 1, P = 0.068).
Those with depressive symptoms (Hamilton ≥ 14) in
the CEA group were 5 (16.6 %) at t0 and 4 (20 %) at t1;
in the control group they were 2 (20 %) at t0 and 2
(20 %) t1. The analysis of variance for Castellan’s nom-
inal data did not detect statistically significant differ-
ences (χ 2 = 0.8, DF = 4, P = 0.723).
Table 3 shows what factors (measured at t0) are asso-
ciated with a positive outcome (improvement in the
Overall IC test by at least 10 points). The sole determin-
ant of outcome appears to have been the younger age.
Patients who acquired a significant improvement in cog-
nitive performance after six months from CEA were
younger (on average by about 7 years) with a statistically
significant difference compared to the age of those who
did not achieve a good outcome in terms of cognitive
performance. The presence of depressive symptoms at
baseline was higher in the group with negative results,
but the difference between the two groups did not reach
the limits of statistical significance. The other factors
(sex, presence of at least one psychiatric diagnosis DSM-
IV, MDQ score, SF-12 score) were homogeneous be-
tween the two groups divided on the basis of outcome.
Patients who underwent surgery with an age above 68
were 23, their mean increase in Overall IC score during
the observation period was 5.65 ± 5.70; those aged 68 or
less were 7, and showed an increase (t0-t1) of 12.42 ±
11.1 in the Overall IC score; the difference was statisti-
cally significant (F = 4.73; DF = 1,18,29; P = 0.038).
In the intervention group (n = 30) a correlation of the
scores of Overall IC and SF12 calculated at t0 was found
(Pearson’s coefficient, 58 DF, r = 0:43 p <0.5), while at t1
(n = 30), the correlation did not reach statistical signifi-
cance (r = 0.145, p > 0.5). In the group of patients not
operated this correlation did not reach statistical signifi-
cance in either of the two measurements t0-t1 (Pearson’s
coefficient, DF = 18, r = 0.172, p > 0.5; r = 0.237, p > 0.5).
Discussion
This is the first study in literature that has measured the
effectiveness of CEA against a control group that did not
undergo the treatment. However, this was not a random-
ized controlled trial, but a cohort study where belonging
to the control group was decided by the same patient
who refused treatment.
The study showed an improvement during the study
(six months) in the mean scores of Overall IC, Perform-
ance IC and Verbal IC in the whole sample of patients
with carotid atherosclerosis, but the improvement was
more marked in the group that underwent CEA. Percep-
tion of quality of life (SF-12 score) and depressive symp-
toms (Hamilton score) improved in the sample over
time but the difference between the two cohorts did not
reach statistical significance.
The figures are perfectly consistent with the fact that
the percentages of patients who improved significantly in
the group that underwent CEA were significantly higher
with regard to Overall and Verbal IC score, and at the
limits of statistical significance in Performance IC (sub-
jects who improved were those with at least 10 points
higher at t1 in Overall, Verbal or Performance IC).
The differences in the percentages of subjects with im-
provement in SF-12 (at least a 5-point increase at t1)
and Hamilton score (30 % decrease) in the two groups
did not reach statistical significance.
The choice to repeat the psychiatric and neuro-
cognitive evaluation after 6 months was determined by
the literature [19, 26], which indicates that an assessment
of cognitive performance made before this time period
may produce erroneous and unreliable results. This
phenomenon may be a consequence of a sudden cerebral
hyperperfusion in months following CEA ([26, 27].
Improvement in cognitive performance after CEA had
been so far described only on the basis of anecdotal or
case studies, rather than through studies with control
groups. Furthermore, the results of these studies were
not completely concordant [28]. An uncontrolled study
showed an improvement in pre-post score WAIS, but
also deterioration in the working memory [29]. In fact,
in a recent systematic review it was impossible to per-
form the meta-analysis owing to the inhomogeneity of
the measuring instruments used and the lack of studies
with control groups [30].
The study by Wassek et al. [31] found a significant
cognitive decline in patients ≥ 68 years, both in patients
treated with CEA and in those treated with the stenting
technique (CAS), but this cognitive impairment per-
sisted in patients after CEA, while it was transient in pa-
tients treated with CAS. The data from our study are
only partially consistent with this result. In our sample,
patients aged under and over 68 years did in fact show
an increase in the score of IC Overall, although the
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Table 3 Determinants of cognitive outcome (Positive outcome at least a 10-point increase in the total score of WAIS Overall IC)
Gender [F] (%) Age SF-12 MDQab MDQ + (%)c Psychiatric Diagnosis (%)a Hamilton Hamilton ≥14 (%)
Overall IC ≥ 10 4 (40) 68.9 ± 6.2 31.8 ± 7.4 3.5 ± 2.8 1 (10) 2 (20) 6.0 ± 5.0 0 (0)
Overall IC <10 9 (45) 75.4 ± 7.7 31.7 ± 7.8 2.5 ± 4.2 3 (15) 5 (25) 7.3 ± 7.1 5 (25)
Total 13 (43) 73.2 ± 7.2 31.8 ± 7.6 2.8 ± 3.7 4 (13.3) 7 (23.3) 6.8 ± 6.4 5 (16.7)
F, ANOVA 1way (Bonferroni)
DF = 1,28,29
F = 5.25* F = 0.01 P = 0.97 F = 0.46 P = 0.53 F = 0.27 P = 0.61
χ 2 with Yates correction DF = 1 χ2 = 0.07 P = 0.79 χ2 = 0.14 P = 0.70 χ2 = 0.09 P = 0.76 χ2 = 1.96 P = 0.16
*p < 0.030
a DSM-IV Anxiety; Mood or Eating Disorders
b Mood Disorder Questionnaire mean score












improvement was more pronounced among younger
people (7 point score mean). It is still to be emphasized
that the evaluation in Wassek’s study was conducted at
3 months, a period much shorter than ours.
The quality of life does not improve differently in the
two cohorts, although the much higher improvement in
the CEA group produces a tendency to a statistically sig-
nificant difference between the two groups over time. It
can be assumed that the improvement of quality of life
needs a longer time than does improvement in cognitive
performance, because the latter may be a determinant in
improvement of the perception of the quality of life. In
fact, on evaluating the correlation between Overall IC
and SF12 scores, a positive correlation at t0 in the co-
hort of the intervention was shown; this correlation was
not apparent at t1 in the same group of subjects who
underwent surgery.
Depressive symptoms did not improve in the treated
group compared to the control group, but we must
emphasize that the average Hamilton scores were mod-
erately low in the two groups and the percentage of
people with a number of depressive symptoms of clinical
relevance was relatively low (≥14 Hamilton score,
around 20 % of the overall sample). In fact, patients with
carotid atherosclerosis comorbid with major depression
in a range between 20–35 % in literature [10–12, 32],
thus the results of this study were at the lower limit of
the range. Owing to the low power of the study, it was
therefore unlikely to find differences even when they
were supposedly present.
Having depressive symptomatology (Hamilton ≥14) at
t0 was associated with a lower outcome (lower IC Over-
all score at t1), but this trend did not reach statistical
significance. Although due to the limit of a small sample
for refusing the null hypothesis, we can say that unlike
previous studies, the results of our study can be com-
pared through meta-analysis with those of future studies
because they were collected with a standardized meth-
odology for measuring outcomes and with a controlled
design.
Limitations
The study was conducted on a small sample, and this
limits its power.
Conclusions
This is the first study in literature that has measured the
effectiveness of CEA against a control group without
treatment and shows that patients with severe carotid
atherosclerosis enhance their cognitive performance if
they undergo CEA in comparison with patients with the
same disorder who refuse surgery.
The study suggests that cognitive decline due to ca-
rotid stenosis can be appropriately prevented if the
treatment for stenosis is conducted early. These results
should be better explained to patients because treat-
ments are frequently not well accepted, probably owing
to the fact that the disorder is asymptomatic in this early
course and the patient does not always feel the need for
treatment.
Given the difficulty of conducting this type of research,
it is essential for future research, even when conducted
on small samples, to maintain a controlled design and
standardized methods of outcome evaluation. This will
allow performance of meta-analyses up to now impos-
sible to carry out.
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